Altreno® (tretinoin) Lotion, 0.05% is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.
Altreno is for topical use only. Not for ophthalmic, oral, or intravaginal use.
Skin Irritation: Patients using Altreno may experience application site dryness, pain, erythema, irritation, and exfoliation.
Patients using Altreno may experience application site dryness, pain, erythema, irritation, and exfoliation. Depending upon the severity of these adverse reactions, instruct patients to use a moisturizer, reduce the frequency of the application of Altreno, or discontinue use. Avoid application of Altreno to eczematous or sunburned skin.
Minimize unprotected exposure to ultraviolet light, including sunlight and sunlamps. Warn patients with frequent sun exposure and those with inherent sensitivity to sunlight to exercise caution. Use sunscreen and protective clothing over treated areas when exposure cannot be avoided.
Altreno contains soluble fish proteins. Use with caution in patients with known sensitivity or allergy to fish. Advise patients to contact their healthcare provider if they develop pruritus or urticaria.
The most common adverse reactions in clinical trials were application site dryness (4%), pain (3%), erythema (2%), irritation (1%) and exfoliation (1%).
It is not known whether topical administration of tretinoin could result in sufficient systemic absorption to produce detectable concentrations in human milk. The developmental health benefits of breastfeeding should be considered along with the mother’s clinical need for Altreno and any potential adverse effects on the breastfed child from Altreno.
To report suspected adverse reactions, contact Customer Service at 1-800-321-4576 or the FDA at 1-800-FDA-1088 or fda.gov/medwatch.
Patients using Altreno may experience application site dryness, pain, erythema, irritation, and exfoliation. Depending upon the severity of these adverse reactions, instruct patients to use a moisturizer, reduce the frequency of the application of Altreno, or discontinue use. Avoid application of Altreno to eczematous or sunburned skin.
Minimize unprotected exposure to ultraviolet light, including sunlight and sunlamps. Warn patients with frequent sun exposure and those with inherent sensitivity to sunlight to exercise caution. Use sunscreen and protective clothing over treated areas when exposure cannot be avoided.
Altreno contains soluble fish proteins. Use with caution in patients with known sensitivity or allergy to fish. Advise patients to contact their healthcare provider if they develop pruritus or urticaria.
The most common adverse reactions in clinical trials were application site dryness (4%), pain (3%), erythema (2%), irritation (1%) and exfoliation (1%).
It is not known whether topical administration of tretinoin could result in sufficient systemic absorption to produce detectable concentrations in human milk. The developmental health benefits of breastfeeding should be considered along with the mother’s clinical need for Altreno and any potential adverse effects on the breastfed child from Altreno.
To report suspected adverse reactions, contact Customer Service at 1-800-321-4576 or the FDA at 1-800-FDA-1088 or fda.gov/medwatch.
Altreno® (tretinoin) Lotion, 0.05% is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.
Altreno is for topical use only. Not for ophthalmic, oral, or intravaginal use.
Skin Irritation: Patients using Altreno may experience application site dryness, pain, erythema, irritation, and exfoliation.
Altreno, the only award-winning tretinoin lotion, with a focus on comfort and hydration.*
*Like all tretinoins, Altreno may cause dryness and irritation.
Altreno, the only award-winning tretinoin lotion, with a focus on comfort and hydration.*
For patients who are worried about dryness and irritation comes the only tretinoin in a hydrating lotion formulation, delivered by a unique polymeric honeycomb mesh delivery system.
Tretinoin is a clinical-strength vitamin A derivative proven to treat acne and enhance both the quality and texture of skin.
Sodium hyaluronate, a form of hyaluronic acid, helps keep skin moisturized throughout the day.
Natural marine collagen helps keep moisture in the skin. The collagen used in Altreno is derived from sole fish*.
Glycerin hydrates, can help protect skin from irritation and may contribute to the healing process.
*Use with caution in patients with known sensitivity or allergy to fish. Advise patients to contact their healthcare provider if they develop pruritus or urticaria.
Tretinoin is a clinical-strength vitamin A derivative proven to treat acne and enhance both the quality and texture of skin.
Sodium hyaluronate, a form of hyaluronic acid, helps keep skin moisturized throughout the day.
Natural marine collagen helps keep moisture in the skin. The collagen used in Altreno is derived from sole fish*.
Glycerin hydrates, can help protect skin from irritation and may contribute to the healing process.
*Use with caution in patients with known sensitivity or allergy to fish. Advise patients to contact their healthcare provider if they develop pruritus or urticaria.
Altreno
(n=767)
Vehicle
(n=783)
Application-site dryness
4%
< 1%
Application-site pain*
3%
< 1%
Application-site erythema
2%
< 1%
Application-site irritation
1%
< 1%
Application-site exfoliation
1%
< 1%
*Application-site pain was defined as application-site stinging, burning, or pain.
01
Altreno 20g
02
Altreno 45g
Altreno® (tretinoin) Lotion, 0.05% is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.
Altreno is for topical use only. Not for ophthalmic, oral, or intravaginal use.
Skin Irritation: Patients using Altreno may experience application site dryness, pain, erythema, irritation, and exfoliation.
Patients using Altreno may experience application site dryness, pain, erythema, irritation, and exfoliation. Depending upon the severity of these adverse reactions, instruct patients to use a moisturizer, reduce the frequency of the application of Altreno, or discontinue use. Avoid application of Altreno to eczematous or sunburned skin.
Minimize unprotected exposure to ultraviolet light, including sunlight and sunlamps. Warn patients with frequent sun exposure and those with inherent sensitivity to sunlight to exercise caution. Use sunscreen and protective clothing over treated areas when exposure cannot be avoided.
Altreno contains soluble fish proteins. Use with caution in patients with known sensitivity or allergy to fish. Advise patients to contact their healthcare provider if they develop pruritus or urticaria.
The most common adverse reactions in clinical trials were application site dryness (4%), pain (3%), erythema (2%), irritation (1%) and exfoliation (1%).
It is not known whether topical administration of tretinoin could result in sufficient systemic absorption to produce detectable concentrations in human milk. The developmental health benefits of breastfeeding should be considered along with the mother’s clinical need for Altreno and any potential adverse effects on the breastfed child from Altreno.
To report suspected adverse reactions, contact Customer Service at 1-800-321-4576 or the FDA at 1-800-FDA-1088 or fda.gov/medwatch.
Altreno is a powerful Rx product, which means it requires a prescription. We can help you get in touch with a healthcare provider in two easy ways:
1. Online consultation
2. In-person visit
